within Pharmacolibrary.Drugs.ATC.D;

model D11AH06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.027,
    Cl             = 187 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,
    adminCount     = 1,
    Vd             = 0.204,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Crisaborole is a topical phosphodiesterase-4 (PDE4) inhibitor used for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children. It is approved and marketed in several countries for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following topical application; population includes male and female subjects without atopic dermatitis.</p><h4>References</h4><ol><li><p>Purohit, V, et al., &amp; Ports, WC (2020). Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis. <i>Journal of clinical pharmacology</i> 60(10) 1344–1354. DOI:<a href=&quot;https://doi.org/10.1002/jcph.1624&quot;>10.1002/jcph.1624</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32433779/&quot;>https://pubmed.ncbi.nlm.nih.gov/32433779</a></p></li><li><p>Zane, LT, et al., &amp; Gold, LS (2016). Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. <i>Immunotherapy</i> 8(8) 853–866. DOI:<a href=&quot;https://doi.org/10.2217/imt-2016-0023&quot;>10.2217/imt-2016-0023</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27283509/&quot;>https://pubmed.ncbi.nlm.nih.gov/27283509</a></p></li><li><p>Zane, LT, et al., &amp; Hebert, AA (2016). Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study. <i>Pediatric dermatology</i> 33(4) 380–387. DOI:<a href=&quot;https://doi.org/10.1111/pde.12872&quot;>10.1111/pde.12872</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27193740/&quot;>https://pubmed.ncbi.nlm.nih.gov/27193740</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D11AH06;
